Your session is about to expire
← Back to Search
Hypofractionated Radiotherapy for Breast Cancer (RHEAL Trial)
RHEAL Trial Summary
This trial is testing whether a shorter, more intense course of radiation therapy is as effective as the standard 3-week course for people with node positive breast cancer.
RHEAL Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowRHEAL Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.RHEAL Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had breast cancer or DCIS on the same side treated with radiation before.My cancer is at an advanced stage, affecting nearby tissues or lymph nodes.I haven't had cancer other than non-melanoma skin cancer or treated in-situ carcinoma in the last 5 years.I am planning to have or have had breast reconstruction.I am receiving hormone therapy before surgery.I have not had radiation on the same side breast or chest wall, nor do I have severe lung, heart disease, or scleroderma.I have had breast cancer in both breasts at the same time or in the past.I have swelling in the same side arm or chest as my cancer.My cancer has not spread to other parts of my body.I am under 18 years old.You live too far away to easily come back for check-up visits.I have recently been diagnosed with breast cancer and have undergone surgery.You have medical conditions that would make it difficult for you to come back for check-ups for 5 years.I am eligible for targeted radiation therapy after my surgery.
- Group 1: Control
- Group 2: Experimental
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this research project being conducted at different locations within the city?
"Presently, this trial is running in 15 locations. These locations include, but are not limited to, Calgary, Edmonton and Toronto. If you are considering participating in this trial, please choose the location nearest you to avoid extensive travel."
What are some potential risks associated with Locoregional radiation treatment - Hypofractionation?
"This particular form of radiation treatment has been studied enough to warrant a score of 3 on our team's safety scale. This is a Phase 3 trial, which means that there is both efficacy and safety data supporting its use."
What is the maximum number of enrollees for this experiment?
"That is correct. The clinical trial, as indicated on clinicaltrials.gov, is still recruiting patients. The trial was posted on February 10th, 2021 and was last updated on October 4th, 2022. The study needs 588 participants from 15 different sites."
Share this study with friends
Copy Link
Messenger